AAV2-FGF18
AssetAlso AAV2-hFGF18
Delivers FGF18 using an adeno-associated virus to promote cartilage anabolism.
- Stage
- Preclinical
- Modality
- Gene therapy
- Target
- FGF18
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Osteoarthritis
Preclinical, remedium-bio.com, 10 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
- Competitors1
Every asset’s record: target, stage, trials and the evidence behind it.